Edson Kuatelela Cassinela
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Edson Kuatelela Cassinela has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Euclides Sacomboio
Universidade Gregório Semedo (UGS), Luanda, Angola
4 shared publications - Cruz Sebastião Sebastião
Centro Nacional de Investigação Científica (CNIC), Luanda, Angola, Angola, Angola
3 shared publications - Adelino Tchilanda Tchivango
Rainha Njinga A Mbande University, Department of Health Sciences, Malanje, Angola
1 shared publication Adriana Franco Paes Leme
Brazilian Biosciences National Laboratory-LNBio, Campinas, Brazil
1 shared publication- Alina María Ruiz-Piedra
Universidad de Ciencias Médicas de La Habana
1 shared publication - Antuani Rafael Baptistella
Universidade do Oeste de Santa Catarina - Unoesc, Joaçaba, Brazil
1 shared publication
Latest Publications
- 17 November 2026
- Published by Infinity Integrated Publishing Center in One Health Microbiology & Infection
- Vol. 2 (1) , 295
Helicobacter pylori infection in Angola: comparative epidemiological patterns identified by serology and stool antigen testing
Helicobacter pylori (H. pylori) is common in low- and middle-income countries, but recent data from Angola are scarce, and positivity estimates and associated factors may vary by diagnostic test used. This prospective cross-sectional sub-study, part of a five-year project on blood group polymorphisms and malaria susceptibility, compared seropositivity and stool antigen positivity to assess whether both tests identify similar epidemiological patterns. Data were collected at two Angolan healthcare facilities between July and September 2025. Of 357 individuals assessed, 172 were eligible and had complete results; no a priori sample size was calculated. H. pylori status was determined by rapid anti-H. pylori IgG serology and stool antigen testing. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were estimated for sociodemographic, clinical, behavioral, environmental, and ABO/Rh factors. Overall, 37.8% of participants were seropositive, and 30.8% were stool antigen-positive. Age ≥ 21 years was associated with seropositivity (OR = 2.17; 95% CI: 1.07–4.42; p = 0.032) and with stool antigen positivity (OR = 2.52; 95% CI: 1.15–5.52; p = 0.021). Living outside Sequele was associated with both outcomes (OR = 4.82; 95% CI: 2.27–10.21 and OR = 5.00; 95% CI: 2.17–11.51, respectively; both p < 0.001). Gastrointestinal symptoms showed strong associations (OR = 193.2; 95% CI: 43.2–864.4 and OR = 86.8; 95% CI: 19.8–380.8; both p < 0.001), but the wide CIs reflect sparse data. Eating outside the home and treating water by methods other than boiling were also associated with positivity. Sex, education, produce washing, ABO group, and Rh factor showed no significant associations. Both tests showed broadly similar patterns, although positivity rates and effect sizes differed. Because antibodies can persist after past infection, whereas stool antigen reflects current infection, the two tests are not equivalent measures of active infection. These facility-based findings do not represent national prevalence; larger, representative studies are needed across Angola.
- 17 November 2026
- Published by Infinity Integrated Publishing Center in One Health Microbiology & Infection
- Vol. 2 (1) , 295
Helicobacter pylori infection in Angola: comparative epidemiological patterns identified by serology and stool antigen testing
Helicobacter pylori (H. pylori) is common in low- and middle-income countries, but recent data from Angola are scarce, and positivity estimates and associated factors may vary by diagnostic test used. This prospective cross-sectional sub-study, part of a five-year project on blood group polymorphisms and malaria susceptibility, compared seropositivity and stool antigen positivity to assess whether both tests identify similar epidemiological patterns. Data were collected at two Angolan healthcare facilities between July and September 2025. Of 357 individuals assessed, 172 were eligible and had complete results; no a priori sample size was calculated. H. pylori status was determined by rapid anti-H. pylori IgG serology and stool antigen testing. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were estimated for sociodemographic, clinical, behavioral, environmental, and ABO/Rh factors. Overall, 37.8% of participants were seropositive, and 30.8% were stool antigen-positive. Age ≥ 21 years was associated with seropositivity (OR = 2.17; 95% CI: 1.07–4.42; p = 0.032) and with stool antigen positivity (OR = 2.52; 95% CI: 1.15–5.52; p = 0.021). Living outside Sequele was associated with both outcomes (OR = 4.82; 95% CI: 2.27–10.21 and OR = 5.00; 95% CI: 2.17–11.51, respectively; both p < 0.001). Gastrointestinal symptoms showed strong associations (OR = 193.2; 95% CI: 43.2–864.4 and OR = 86.8; 95% CI: 19.8–380.8; both p < 0.001), but the wide CIs reflect sparse data. Eating outside the home and treating water by methods other than boiling were also associated with positivity. Sex, education, produce washing, ABO group, and Rh factor showed no significant associations. Both tests showed broadly similar patterns, although positivity rates and effect sizes differed. Because antibodies can persist after past infection, whereas stool antigen reflects current infection, the two tests are not equivalent measures of active infection. These facility-based findings do not represent national prevalence; larger, representative studies are needed across Angola.
- 22 October 2025
- Published by Rede Academica das Ciencias da Saude da Lusofonia in RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia
- Vol. 7 (3)
Factors associated with vaccine hesitation in the angolan population
A hesitação vacinal é um problema de saúde pública. O objetivo do estudo foi determinar os fatores associados à hesitação vacinal na população angolana. Realizou-se um estudo observacional, analítico, prospetivo e transversal, com uma amostra probabilística de 1066 habitantes em 9 províncias e 78 municípios. Participaram 485 crianças menores de 5 anos, sendo os pais as unidades de informação, e 581 adultos. Critérios de inclusão: atendimento nos postos de vacinação durante o período do estudo e aceitação voluntária. Aplicou-se um questionário para cada grupo, com fiabilidade acima de 60%. A variável principal “considera importante a vacinação”, dividiu cada grupo em dois. As unidades de estudo foram caracterizadas através de frequência absoluta, percentagem, média e desvio padrão. Utilizou-se o teste do qui-quadrado e o Odds Ratio (OR) como medidas de associação e de risco. Resultados: No grupo das crianças, treze variáveis foram identificadas como fatores de risco para recusar a vacina, destacando-se como o maior risco a variável “considerar as vacinas seguras” (OR=11,51, p=0.000), enquanto duas se mostraram protetoras, como “às vezes não há vacinas disponíveis”. Entre os adultos, nove variáveis foram classificadas como fatores de risco, com destaque para a “satisfação com o serviço de saúde” (OR=6,8), além de duas variáveis protetoras, como “distância ao centro de saúde”. Conclusões: A vacinação em crianças e adultos mostrou que os fatores que diminuem a hesitação vacinal são a satisfação com o serviço sanitário e a confiança nos profissionais de saúde, embora nem sempre estivesse disponível a vacina reforça a ideia de existir a hesitação.
- 22 October 2025
- Published by Rede Academica das Ciencias da Saude da Lusofonia in RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia
- Vol. 7 (3)
Factors associated with vaccine hesitation in the angolan population
A hesitação vacinal é um problema de saúde pública. O objetivo do estudo foi determinar os fatores associados à hesitação vacinal na população angolana. Realizou-se um estudo observacional, analítico, prospetivo e transversal, com uma amostra probabilística de 1066 habitantes em 9 províncias e 78 municípios. Participaram 485 crianças menores de 5 anos, sendo os pais as unidades de informação, e 581 adultos. Critérios de inclusão: atendimento nos postos de vacinação durante o período do estudo e aceitação voluntária. Aplicou-se um questionário para cada grupo, com fiabilidade acima de 60%. A variável principal “considera importante a vacinação”, dividiu cada grupo em dois. As unidades de estudo foram caracterizadas através de frequência absoluta, percentagem, média e desvio padrão. Utilizou-se o teste do qui-quadrado e o Odds Ratio (OR) como medidas de associação e de risco. Resultados: No grupo das crianças, treze variáveis foram identificadas como fatores de risco para recusar a vacina, destacando-se como o maior risco a variável “considerar as vacinas seguras” (OR=11,51, p=0.000), enquanto duas se mostraram protetoras, como “às vezes não há vacinas disponíveis”. Entre os adultos, nove variáveis foram classificadas como fatores de risco, com destaque para a “satisfação com o serviço de saúde” (OR=6,8), além de duas variáveis protetoras, como “distância ao centro de saúde”. Conclusões: A vacinação em crianças e adultos mostrou que os fatores que diminuem a hesitação vacinal são a satisfação com o serviço sanitário e a confiança nos profissionais de saúde, embora nem sempre estivesse disponível a vacina reforça a ideia de existir a hesitação.
- Open Access
- 5 August 2024
- Published by MDPI AG in Preprints.org
Dynamics of Liver Function among Patients with Malaria in Luanda, Angola: A Cross-Sectional Study
Background: Malaria continues a concern in Angola. Liver dysfunction is a relevant feature of malaria. There is no published study exploring liver function dynamics during P.falciparum infection in Angola.Objectives: We investigated the dynamics of liver function among patients with malaria in Luanda, Angola.Methods: This was a cross-sectional study performed with 199 malaria patients, from March-August 2023.Results: About 71% of the patients had low parasitemia, moderate disease(54%), and used Artesunato(39.7%). Decrease in ALT(68.7 to 50.7) was observed from non-severe to severe with increases in AST(56.6 to 134, pppConclusions: Several malarian patients could present high AST, ALT, GGT, and Bilirubin values indicating putative liver failure during malaria treatment in Angola.
- 5 August 2024
- Published by MDPI AG in Preprints.org
Open AccessDynamics of Liver Function among Patients with Malaria in Luanda, Angola: A Cross-Sectional Study
Background: Malaria continues a concern in Angola. Liver dysfunction is a relevant feature of malaria. There is no published study exploring liver function dynamics during P.falciparum infection in Angola.Objectives: We investigated the dynamics of liver function among patients with malaria in Luanda, Angola.Methods: This was a cross-sectional study performed with 199 malaria patients, from March-August 2023.Results: About 71% of the patients had low parasitemia, moderate disease(54%), and used Artesunato(39.7%). Decrease in ALT(68.7 to 50.7) was observed from non-severe to severe with increases in AST(56.6 to 134, pppConclusions: Several malarian patients could present high AST, ALT, GGT, and Bilirubin values indicating putative liver failure during malaria treatment in Angola.
- Open Access
- 4 December 2023
- Published by MDPI AG in Preprints.org
Urinalysis Results and Resistance to Hospital Treatment with Injectable Antimalarials in Angola
Background: Resistance to antimalarial drugs often used in emerging countries, including combination therapies, has forced scientists to search for and develop drugs with novel mechanisms of action, especially resistance to Plasmodium falciparum and Plasmodium vivax, which are highly prevalent in Southeast Asia, Africa, and South America. Objective: evaluate whether there is a relationship between urinalysis and resistance to in-hospital treatment of malaria in Angola. Methodology: This was a cross-sectional, prospective study with a quantitative approach. Results: of the 214 patients, the resistance rate was 24.1%, men (53.6%), between 21 and 40 years old (72.7%), employees (46.4%), from peri-urban regions (77.7%), treated with artemether (90.9), with high parasitemia (57.7%) and after 5 days of treatment, remained hospitalized (61.4%). Was a significant relationship between resistance in unemployed individuals [OR: 0.03 (95% CI: 0.01-0.29), p =0.003] and high levels of parasitemia [OR: 1.09 (95% CI: 1.09-3.95), p=0.040], remained hospitalized for more than 5 days [OR: 5.28 (95% CI: 0.65-43.1), p=0.121] and death [OR: 2.59 (95% CI: 0.32-20.9), p=0.371] when compared with other subgroups. Was a significant relationship between resistance to clear urine [OR: 5.55 (95% CI: 0.72-42.7), p =0.016], few urinary crystals [OR: 11.3 (95% CI: 5.07-25.3), p <0.001] and who presented some microorganisms that were not bacteria or fungi [OR: 3.02 (95% CI: 1 .32-6.90), p=0.009]. Conclusion: urine results, especially the appearance of cloudy urine, the presence of few crystals, and the presence of other microorganisms that are not bacteria or fungi, may be clear signs of resistance to hospital treatment with injectable antimalarials.
- 4 December 2023
- Published by MDPI AG in Preprints.org
Open AccessUrinalysis Results and Resistance to Hospital Treatment with Injectable Antimalarials in Angola
Background: Resistance to antimalarial drugs often used in emerging countries, including combination therapies, has forced scientists to search for and develop drugs with novel mechanisms of action, especially resistance to Plasmodium falciparum and Plasmodium vivax, which are highly prevalent in Southeast Asia, Africa, and South America. Objective: evaluate whether there is a relationship between urinalysis and resistance to in-hospital treatment of malaria in Angola. Methodology: This was a cross-sectional, prospective study with a quantitative approach. Results: of the 214 patients, the resistance rate was 24.1%, men (53.6%), between 21 and 40 years old (72.7%), employees (46.4%), from peri-urban regions (77.7%), treated with artemether (90.9), with high parasitemia (57.7%) and after 5 days of treatment, remained hospitalized (61.4%). Was a significant relationship between resistance in unemployed individuals [OR: 0.03 (95% CI: 0.01-0.29), p =0.003] and high levels of parasitemia [OR: 1.09 (95% CI: 1.09-3.95), p=0.040], remained hospitalized for more than 5 days [OR: 5.28 (95% CI: 0.65-43.1), p=0.121] and death [OR: 2.59 (95% CI: 0.32-20.9), p=0.371] when compared with other subgroups. Was a significant relationship between resistance to clear urine [OR: 5.55 (95% CI: 0.72-42.7), p =0.016], few urinary crystals [OR: 11.3 (95% CI: 5.07-25.3), p <0.001] and who presented some microorganisms that were not bacteria or fungi [OR: 3.02 (95% CI: 1 .32-6.90), p=0.009]. Conclusion: urine results, especially the appearance of cloudy urine, the presence of few crystals, and the presence of other microorganisms that are not bacteria or fungi, may be clear signs of resistance to hospital treatment with injectable antimalarials.
- Open Access
- 11 January 2023
- Published by Wiley in Health Science Reports
- Vol. 6 (1) , e1058
Immune profile of healthcare professionals six months after vaccination or exposure to SARS‐CoV‐2 in Angola
Background and Aims: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection is a public health concern. Until 2021, more than 2 million cumulative deaths were reported worldwide. Herein, we investigated the immune profile of healthcare professionals 6 months after vaccination or exposure to SARS‐CoV‐2 in Angola.Methods: This was a prospective study conducted with 1068 Angolan healthcare professionals between August and December 2021. Participants were screened for the presence of IgG and IgM against SARS‐CoV‐2.Results: About 9.6% and 98.2% of the participants had prior exposure to SARS‐CoV‐2 or vaccination against it, respectively. Participants aged between 20 and 40 years (11.2%), female (12.4%), with higher educational level (12.8%), from Luanda (60.3%), and nonhealthcare professionals (8.1%) were the most affected by the SARS‐CoV‐2. Gender, education, and local residence were related to SARS‐CoV‐2 exposure (p < 0.05). About 7.3% and 98% of the exposed population developed IgM and IgG after 3 months of exposure, respectively. The AstraZeneca vaccine was the most used, followed by the Jonhson & Johnson and Sputinik. Almost all (98%) participants vaccinated with AstraZeneca had immunity >3 months. Individuals who received only the first dose regardless of the type of vaccine had a higher immunity duration (>3 months) than those who received two doses. For individuals who received the Sputnik and Johnson, the average immunity was lower (<3 months), especially among those who were older (over 40 years old) and exposed to SARS‐CoV‐2.Conclusion: We observed a high adherence rate to vaccination and a long immunity duration. The immunity duration depended on the type of vaccine. Further studies on the immunity profile in the population exposed to SARS‐CoV‐2 must be carried out in the general population from Angola to assess antibody‐waning periods.
- 11 January 2023
- Published by Wiley in Health Science Reports
- Vol. 6 (1) , e1058
Open AccessImmune profile of healthcare professionals six months after vaccination or exposure to SARS‐CoV‐2 in Angola
Background and Aims: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection is a public health concern. Until 2021, more than 2 million cumulative deaths were reported worldwide. Herein, we investigated the immune profile of healthcare professionals 6 months after vaccination or exposure to SARS‐CoV‐2 in Angola.Methods: This was a prospective study conducted with 1068 Angolan healthcare professionals between August and December 2021. Participants were screened for the presence of IgG and IgM against SARS‐CoV‐2.Results: About 9.6% and 98.2% of the participants had prior exposure to SARS‐CoV‐2 or vaccination against it, respectively. Participants aged between 20 and 40 years (11.2%), female (12.4%), with higher educational level (12.8%), from Luanda (60.3%), and nonhealthcare professionals (8.1%) were the most affected by the SARS‐CoV‐2. Gender, education, and local residence were related to SARS‐CoV‐2 exposure (p < 0.05). About 7.3% and 98% of the exposed population developed IgM and IgG after 3 months of exposure, respectively. The AstraZeneca vaccine was the most used, followed by the Jonhson & Johnson and Sputinik. Almost all (98%) participants vaccinated with AstraZeneca had immunity >3 months. Individuals who received only the first dose regardless of the type of vaccine had a higher immunity duration (>3 months) than those who received two doses. For individuals who received the Sputnik and Johnson, the average immunity was lower (<3 months), especially among those who were older (over 40 years old) and exposed to SARS‐CoV‐2.Conclusion: We observed a high adherence rate to vaccination and a long immunity duration. The immunity duration depended on the type of vaccine. Further studies on the immunity profile in the population exposed to SARS‐CoV‐2 must be carried out in the general population from Angola to assess antibody‐waning periods.
- Open Access
- 1 January 2022
- Published by Universidade do Estado do Mato Grosso - UNEMAT in Journal Health NPEPS
- Vol. 7 (2) , e6510
Fatores associados ao baixo apgar em recém-nascidos angolanos
Objetivo: avaliar os fatores associados ao baixo Apgar em recém-nascidos de Angola. Método: estudo analitíco e transversal, quali-quantitativo entre março e maio de 2021, realizado no Hospital Geral de Luanda, Angola. Realizou-se entrevistas em sala de espera e consulta aos prontuários das parturientes. Os dados foram analisados pelo teste qui-quadrado (X2) e regressão logística. Resultados: prevaleceu parturientes entre 19-35 anos (70,0%), 7º-9º ano (57,5%), multíparas (75%), multigestas (75,0%), sem histórico de aborto (72,5%), idade gestacional de 40 semanas (60,0%), usuárias de bebidas alcoólicas (77,5%), baixa frequência de consultas pré-natais (52,5%), com parto natural (82,5%) e recém-nascidos com peso normal (52,5%). Mulheres de região periurbana [OR:6,85 (95% CI:0.65-71,2), p=0,108] e rural [OR:4,47 (95% CI:0.47-48,4), p=0,184] apresentaram maior chance de terem recém-nascidos com baixo Apgar, assim como as usuárias de álcool [OR:3,28 (95% CI:0,58-18,3), p=0,176] e recém-nascidos que nasceram com peso normal [OR:1,75 (95% CI:0,49–6,22), p=0,387]. Não houve associação estatística entre os dados sociodemográficos e maternos. Conclusão: a faixa etária, local de residência, consumo de álcool materno e peso do recém-nascido podem implicar em baixo Apgar.
- 1 January 2022
- Published by Universidade do Estado do Mato Grosso - UNEMAT in Journal Health NPEPS
- Vol. 7 (2) , e6510
Open AccessFatores associados ao baixo apgar em recém-nascidos angolanos
Objetivo: avaliar os fatores associados ao baixo Apgar em recém-nascidos de Angola. Método: estudo analitíco e transversal, quali-quantitativo entre março e maio de 2021, realizado no Hospital Geral de Luanda, Angola. Realizou-se entrevistas em sala de espera e consulta aos prontuários das parturientes. Os dados foram analisados pelo teste qui-quadrado (X2) e regressão logística. Resultados: prevaleceu parturientes entre 19-35 anos (70,0%), 7º-9º ano (57,5%), multíparas (75%), multigestas (75,0%), sem histórico de aborto (72,5%), idade gestacional de 40 semanas (60,0%), usuárias de bebidas alcoólicas (77,5%), baixa frequência de consultas pré-natais (52,5%), com parto natural (82,5%) e recém-nascidos com peso normal (52,5%). Mulheres de região periurbana [OR:6,85 (95% CI:0.65-71,2), p=0,108] e rural [OR:4,47 (95% CI:0.47-48,4), p=0,184] apresentaram maior chance de terem recém-nascidos com baixo Apgar, assim como as usuárias de álcool [OR:3,28 (95% CI:0,58-18,3), p=0,176] e recém-nascidos que nasceram com peso normal [OR:1,75 (95% CI:0,49–6,22), p=0,387]. Não houve associação estatística entre os dados sociodemográficos e maternos. Conclusão: a faixa etária, local de residência, consumo de álcool materno e peso do recém-nascido podem implicar em baixo Apgar.
- 9 April 2019
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 97 (6) , 855-869
Rab5C enhances resistance to ionizing radiation in rectal cancer
Rectal cancer represents one third of the colorectal cancers that are diagnosed. Neoadjuvant chemoradiation is a well-established protocol for rectal cancer treatment reducing the risk of local recurrence. However, a pathologic complete response is only achieved in 10–40% of cases and the mechanisms associated with resistance are poorly understood. To identify potential targets for preventing therapy resistance, a proteomic analysis of biopsy specimens collected from stage II and III rectal adenocarcinoma patients before neoadjuvant treatment was performed and compared with residual tumor tissues removed by surgery after neoadjuvant therapy. Three proteins, Ku70, Ku80, and Rab5C, exhibited a significant increase in expression after chemoradiation. To better understand the role of these proteins in therapy resistance, a rectal adenocarcinoma cell line was irradiated to generate a radiotherapy-resistant lineage. These cells overexpressed the same three proteins identified in the tissue samples. Furthermore, radiotherapy resistance in this in vitro model was found to involve modulation of epidermal growth factor receptor (EGFR) internalization by Rab5C in response to irradiation, affecting expression of the DNA repair proteins, Ku70 and Ku80, and cell resistance. Taken together, these findings indicate that EGFR and Rab5C are potential targets for the sensitization of rectal cancer cells and they should be further investigated.
- 9 April 2019
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 97 (6) , 855-869
Rab5C enhances resistance to ionizing radiation in rectal cancer
Rectal cancer represents one third of the colorectal cancers that are diagnosed. Neoadjuvant chemoradiation is a well-established protocol for rectal cancer treatment reducing the risk of local recurrence. However, a pathologic complete response is only achieved in 10–40% of cases and the mechanisms associated with resistance are poorly understood. To identify potential targets for preventing therapy resistance, a proteomic analysis of biopsy specimens collected from stage II and III rectal adenocarcinoma patients before neoadjuvant treatment was performed and compared with residual tumor tissues removed by surgery after neoadjuvant therapy. Three proteins, Ku70, Ku80, and Rab5C, exhibited a significant increase in expression after chemoradiation. To better understand the role of these proteins in therapy resistance, a rectal adenocarcinoma cell line was irradiated to generate a radiotherapy-resistant lineage. These cells overexpressed the same three proteins identified in the tissue samples. Furthermore, radiotherapy resistance in this in vitro model was found to involve modulation of epidermal growth factor receptor (EGFR) internalization by Rab5C in response to irradiation, affecting expression of the DNA repair proteins, Ku70 and Ku80, and cell resistance. Taken together, these findings indicate that EGFR and Rab5C are potential targets for the sensitization of rectal cancer cells and they should be further investigated.
- Open Access
- 1 December 2018
- Published by FapUNIFESP (SciELO) in Genetics and Molecular Biology
- Vol. 41 (4) , 806-813
Comparative cytogenetics in three Melipona species (Hymenoptera: Apidae) with two divergent heterochromatic patterns
The genus Melipona is subdivided into four subgenera based on morphological characteristics, and two groups based on cytogenetic patterns. The cytogenetic information on this genus is still scarce, therefore, the goal of this study was to characterize Melipona paraensis, Melipona puncticollis, and Melipona seminigra pernigra using the following techniques: C-banding, DAPI/CMA3 fluorochromes, and FISH with an 18S rDNA probe. Melipona paraensis (2n=18) and M. seminigra pernigra (2n=22) were classified as high heterochromatin content species (Group II). Their euchromatin is restricted to the ends of the chromosomes and is CMA3+; the 18S rDNA probe marked chromosome pair number 4. Melipona puncticollis (2n=18) is a low heterochromatin content species (Group I) with chromosome pair number 1 marked with CMA3 and 18S rDNA. Low heterochromatin content is a putative ancestral karyotype in this genus and high content is not a monophyletic trait (Melikerria presents species with both patterns). Differences concerning the karyotypic characteristics can be observed among Melipona species, revealing cytogenetic rearrangements that occurred during the evolution of this genus. Studies in other species will allow us to better understand the processes that shaped the chromatin evolution in Melipona.
- 1 December 2018
- Published by FapUNIFESP (SciELO) in Genetics and Molecular Biology
- Vol. 41 (4) , 806-813
Open AccessComparative cytogenetics in three Melipona species (Hymenoptera: Apidae) with two divergent heterochromatic patterns
The genus Melipona is subdivided into four subgenera based on morphological characteristics, and two groups based on cytogenetic patterns. The cytogenetic information on this genus is still scarce, therefore, the goal of this study was to characterize Melipona paraensis, Melipona puncticollis, and Melipona seminigra pernigra using the following techniques: C-banding, DAPI/CMA3 fluorochromes, and FISH with an 18S rDNA probe. Melipona paraensis (2n=18) and M. seminigra pernigra (2n=22) were classified as high heterochromatin content species (Group II). Their euchromatin is restricted to the ends of the chromosomes and is CMA3+; the 18S rDNA probe marked chromosome pair number 4. Melipona puncticollis (2n=18) is a low heterochromatin content species (Group I) with chromosome pair number 1 marked with CMA3 and 18S rDNA. Low heterochromatin content is a putative ancestral karyotype in this genus and high content is not a monophyletic trait (Melikerria presents species with both patterns). Differences concerning the karyotypic characteristics can be observed among Melipona species, revealing cytogenetic rearrangements that occurred during the evolution of this genus. Studies in other species will allow us to better understand the processes that shaped the chromatin evolution in Melipona.